This is an open-label, Phase 3 clinical trial evaluating the efficacy of Tofacitinib based on remission in children with moderate to severe ulcerative colitis. The effects will be evaluated during an induction, maintenance, and extension period of taking the medication. Physical exams, blood and stool sample collection, and sporadic endoscopic evaluation are planned to take place throughout these periods.